I-125cm yabantu abadala abancinci iTifa yokwenene yothando lweSex Dolls

Usulelo lokuphumelela kunye ne-boosters

Iindaba ezimnandi zezokuba idosi epheleleyo yezitofu ezigunyazisiweyo ze-COVID-19 zisasebenza. “Zonke izitofu zokugonya zisebenza kakuhle,” utshilo uJeff Kwong, ugqirha wezifo ezosulelayo kwiDyunivesithi yaseToronto. “Kwaye izitofu zokugonya bezikhusela ngakumbi kwiziphumo ezibi xa kuthelekiswa nolosulelo lweempawu,” uKwong ubonisile kuphononongo, olungekaphononongwa ngoontanga, ukusebenza kogonyo lwePfizer, Moderna, kunye ne-AstraZeneca ngokuchasene nosulelo oluneempawu, ukulaliswa esibhedlele, okanye ukufa phakathi kukaDisemba ka-2020. kwaye May 2021.Robot Sex Doll

Uphononongo oluninzi lubonise ukuba izitofu zokugonya zeModerna kunye nePfizer zisakhusela iDelta, nangona kungenjalo ngokunjalo ngokuchasene nokwahluka kwangaphambili. Abantu abangagonywanga benza ngaphezulu kweepesenti ezingama-90 zamatyala amatsha aqinisekisiweyo phakathi kwamazwe alandelela idatha yetyala kunye nesimo sokugonywa.

“[Ugonyo] luyawunciphisa kakhulu umngcipheko weziphumo ezibi njengokulaliswa esibhedlele,” utshilo uAziz Sheikh, ingcali yokhathalelo oluphambili kwiYunivesithi yase-Edinburgh, eSkotlani, e-UK ebonise ukuba iDelta ibangele ukulaliswa esibhedlele ngokuphindwe kabini kunokwahluka kwe-Alpha, ethe yabangela ukuba abantu balaliswe esibhedlele. kubangele ukugula okuqatha ngakumbi kune-SARS-CoV-2 yokuqala. Ngokubanzi, bayasebenza. "Oonodoli beSilicone ngesondo

I-CDC iqikelela ukuba ugonyo lwe-COVID-19 lunciphisa umngcipheko wosulelo lwe-SARS-CoV-2 ngokuphindwe kasibhozo kunye nomngcipheko wokugula, ukulaliswa esibhedlele, okanye ukusweleka ngokuphindwe ka-25.

Kodwa uvavanyo olungonelanga kwilizwe lonke lwenza ukuba kube nzima ukwazi ubungakanani bokwenyani bokusasazeka kweDelta kunye nezinye izinto ezahlukeneyo. Xa kukho usulelo oluphezulu lweDelta eluntwini, nabantu abagonywe ngokupheleleyo basengozini kwinto ebizwa ngokuba “lusulelo lokugonya,” oluchazwa yiCDC njengaxa imathiriyeli yemfuza okanye iprotein evela kwaSARS-CoV-2 ibonakala kwiswab yeempumlo ngakumbi. ngaphezu kweentsuku ezili-14 emva kokuba umntu efumene idosi ecetyiswayo yesitofu sokugonya se-COVID-19 esigunyaziswe yi-FDA. Unodoli weSex oneFurry

Iidosi ezimbini ze-AstraZeneca kunye ne-Pfizer yokugonya kuqikelelwa ukuba yi-60 kunye ne-88 yeepesenti ezisebenzayo, ngokulandelanayo, ngokuchasene nesifo se-symptomatic esibangelwa yi-Delta. Uninzi lwezitofu zokugonya ezilawulwa e-US (i-Moderna kunye ne-Pfizer) zifuna izitofu ezimbini zokhuseleko oluphezulu. Ezi zitofu zingasebenzi kangako ngokuchasene neDelta emva nje kwejab enye, utshilo u-Olivier Schwartz, intloko yeYunithi yeNtsholongwane kunye noKhuseleko e-Institut Pasteur, eParis, owayekhokele uphononongo olwabonisa ukuba idosi enye ye-AstraZeneca kunye nogonyo lwe-Pfizer okanye usulelo lwangaphambili. ngokulambisa ukwahluka kweDelta.

Ikhuthazwa yidatha ekuncitshisweni kokuchaneka kwezinto ezahlukeneyo ezinje ngeDelta, iPfizer ifuna ugunyaziso lwedosi ye-booster yesitofu sokugonya. IModerna ikwavavanya idosi ehlaziyiweyo yesitofu sokugonya se-mRNA. Ulawulo lokutya kunye neziyobisi lwase-US (i-FDA) kulindeleke ukuba lugqibezele isicwangciso sokukhuthaza isitofu se-COVID-19 kungekudala.